A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

N.M. Weathington; A.H. van Houwelingen; B.D. Noerager; P.L. Jackson; A.D. Kraneveld; F.S. Galin; G. Folkerts; F.P. Nijkamp; J.E. Blalock

doi:10.1038/nm1361

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

N.M. Weathington, A.H. van Houwelingen, B.D. Noerager, P.L. Jackson, A.D. Kraneveld, F.S. Galin, G. Folkerts, F.P. Nijkamp, J.E. Blalock^*

^*Corresponding author for this work

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	317-323
Number of pages	7
Journal	Nature Medicine
Volume	12
Issue number	3
DOIs	https://doi.org/10.1038/nm1361
Publication status	Published - 2006

Funding

The authors acknowledge J. Downs (Pfizer Inc.) for the gift of the 9A4 monoclonal antibody, the laboratory of J. Oppenheim (US National Institutes of Health) for providing the CXCR-transfected cells, and P. O’Reilley, W. Bailey and K. Young for advice. We thank S. Parker of the University of Alabama at Birmingham (UAB) Core Facility for Collection, Processing and Storage of Alveolar Fluid for clinical samples and the UAB Mass Spectrometry Core Facility for sample analysis. This work was supported by US National Institutes of Health grants HL68806 (to J.E.B.), T32HL007553 (to B.D.N.), T32 GM63490 (to B.D.N.), T32 GM008361 (to N.M.W.) and F30 ES13874 (to N.M.W.).

Keywords

Farmacie(FARM)
Biomedische technologie en medicijnen
Immunology
Pharmacology
Overig medisch onderzoek

Access to Document

10.1038/nm1361

Cite this

@article{508cfb7643b6464eadd7a98aaa8142d6,

title = "A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation",

keywords = "Farmacie(FARM), Biomedische technologie en medicijnen, Immunology, Pharmacology, Overig medisch onderzoek",

author = "N.M. Weathington and {van Houwelingen}, A.H. and B.D. Noerager and P.L. Jackson and A.D. Kraneveld and F.S. Galin and G. Folkerts and F.P. Nijkamp and J.E. Blalock",

year = "2006",

doi = "10.1038/nm1361",

language = "English",

volume = "12",

pages = "317--323",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "3",

}

TY - JOUR

T1 - A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

AU - Weathington, N.M.

AU - van Houwelingen, A.H.

AU - Noerager, B.D.

AU - Jackson, P.L.

AU - Kraneveld, A.D.

AU - Galin, F.S.

AU - Folkerts, G.

AU - Nijkamp, F.P.

AU - Blalock, J.E.

PY - 2006

Y1 - 2006

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Immunology

KW - Pharmacology

KW - Overig medisch onderzoek

UR - http://www.scopus.com/inward/record.url?scp=33644828187&partnerID=8YFLogxK

U2 - 10.1038/nm1361

DO - 10.1038/nm1361

M3 - Article

C2 - 16474398

SN - 1078-8956

VL - 12

SP - 317

EP - 323

JO - Nature Medicine

JF - Nature Medicine

IS - 3

ER -

A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation

Funding

Keywords

Access to Document

Other files and links

Cite this